About the Authors
- John Peabody
-
Contributed equally to this work with: John Peabody, Michael Paul
* E-mail: jpeabody@qurehealthcare.com
Affiliations University of California, San Francisco, CA, United States of America, University of California, Los Angeles, CA, United States of America, QURE Healthcare, San Francisco, CA, United States of America
- Megan Martin
-
Affiliation Lineagen, Salt Lake City, UT, United States of America
- Lisa DeMaria
-
Affiliation QURE Healthcare, San Francisco, CA, United States of America
- Jhiedon Florentino
-
Affiliation QURE Healthcare, San Francisco, CA, United States of America
- David Paculdo
-
Affiliation QURE Healthcare, San Francisco, CA, United States of America
- Michael Paul
-
Contributed equally to this work with: John Peabody, Michael Paul
Affiliation Lineagen, Salt Lake City, UT, United States of America
- Rena Vanzo
-
Affiliation Lineagen, Salt Lake City, UT, United States of America
- E. Robert Wassman
-
¶‡ These authors also contributed equally to this work.
Affiliation Lineagen, Salt Lake City, UT, United States of America
- Trever Burgon
-
¶‡ These authors also contributed equally to this work.
Affiliation QURE Healthcare, San Francisco, CA, United States of America
Competing Interests
The authors have the following interests: MM, MP, RV, and EBW are employees of Lineagen, Inc; LD, JF, DP, and TB are all employees of QURE Healthcare. JP is the President of CPV Technologies, which owns the CPV IP used in the study. This does not alter our adherence to PLOS ONE policies on sharing data and materials.
Author Contributions
Conceptualization: JP MM MP. Data curation: JF DP. Formal analysis: JF DP. Funding acquisition: MP RV ERW. Investigation: JP LD TB. Methodology: JP LD JF. Project administration: MM LD. Resources: JP MP RV. Software: JP LD. Supervision: JP MP RV ERW. Validation: JP DP. Writing – original draft: JP MM LD MP RV. Writing – review & editing: JP MM LD JF DP MP RV ERW TB.